ICD-10 transition: Overcoming bottlenecks of neutrality risks
Despite the one-year extension on the ICD-10 compliance deadline, many organizations are still struggling to comprehend the real drivers of neutrality risk. The far-reaching implications of the delay will ultimately hinder the efforts of organizations to manage compliance on a risk-free basis.
The present-day myopic view for neutrality assessment leads to an internal vacuum. Organizations largely suffer as a result without adequate visibility into the actual causes. However, with increased maturity of the ICD-10 learning curve, pragmatic organizations are changing their notion on neutrality. They are increasingly recognizing it as a more complex problem. With this understanding, organizations are trying to address the issue at an enterprise level to achieve neutrality comprehensively through financial optimization, clinical integrity, and operational stability.
Reproduced with permission from Executive Insights
Dr. Suman De, Healthcare Consultant and Head-ICD-10, Infosys Public Services
Dr. Suman De is a registered clinician with a bachelor’s degree in medicine and a master’s degree in business administration (healthcare). He leads the iTransform™ product development team. Dr. Suman has extensive experience in the healthcare domain, and he specializes in the development and implementation of IT-enabled business solutions for health insurance and managed care organizations (MCOs).
Infosys ICD-10 Neutrality Analytics Solution
Case study: JFK Health readies for ICD-10 transition